Danube Labs

🚀 A Major Milestone for Danube Labs! 🚀 We are proud to announce the launch of #TAGTherapeutics, the first biotech start-up emerging from our acceleration program created by CEBINA , Evotec, and Danube BioVentures. TAG Therapeutics is developing Teloblock™, an antisense oligonucleotide (ASO)-based precision medicine platform designed to target telomere pathologies and age-related diseases, and originates from the pioneering research of Dr. Fabrizio d'Adda di Fagagna at IFOM. The launch of TAG Therapeutics highlights our mission at Danube Labs: accelerating promising academic research into real-world biotech ventures. We’re excited to see TAG advancing toward clinical development, with the potential to transform the treatment landscape for telomere-related diseases. #DanubeLabs #LifeScienceAcceleration #BiotechStartUp #TelomereTherapeutics #PrecisionMedicine #AgeRelatedDiseases #InnovationInBiotech

Absolutely thrilled to announce that Danube Labs has entered into a collaboration with Gdański Uniwersytet Medyczny (Medical University of Gdańsk)! 🚀🚀 This new collaboration will fast-track a selected project towards commercialization with crucial in vitro and in vivo studies, together with our partners CEBINA Evotec and CEBINA Bridge Capital   #Biotech #Innovation #DrugDiscovery #Collaboration #Science #Research

We are delighted to announce that Danube Labs has entered into a collaboration with IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and its tech-transfer office IOCB Tech! 🚀🚀 This new collaboration will enable us to fast-track a selected project towards commercialization with crucial in vivo studies, together with our partners CEBINA , Evotec and CEBINA Bridge Capital   #Biotech #Innovation #DrugDiscovery #Collaboration #Science #Research

Less than 24 hours to our first DanubeNeuro #webinar - looking forward to introducing our new #accelerator program dedicated to #neuroscienceresearch, #neurodegeneration, #aging, and #dementia!

The CEBINA accelerator portfolio is growing! Thrilled to see DanubeNeuro unveiled today 🚀🚀🚀 Learn more at https://lnkd.in/dYgxUraF #BiotechInnovation #Neuroscience #InnovateWithUs #biotechaccelerator 

A very interesting white paper from our colleagues at Evotec on the journey from #academic innovation to the market - looking forward to the next chapter! #Research #Innovation #AcademicExcellence #WhitePaper #collaboration